Dr. Miguel Moital, Principal Academic in Events Management within the Department of Events & Leisure, has been appointed international expert and external examiner for the Portuguese Agency for Assessment and Accreditation of Higher Education – A3ES. The agency validates and re-validates programmes at graduate, postgraduate and Doctoral level.
Every 6 years accredited programmes have to request re-validation, with the process including a visit to the University by a panel made up of two national academics, an international expert, a student and a representative of the agency. The day long visit includes meetings with the dean, the quality assurance manager, the programme leadership team, the teaching team, and student and alumni representatives. Each visit also includes a working lunch with employers and institutional partners. The ethos of the exercise is to evaluate whether the course meets minimum quality standards as well as to engage in discussions of possible measures that could contribute to improving the quality of the programme.
Dr. Moital has recently carried out two programme revalidations in Porto and will travel again in November to undertake a further two in Lisbon.











The significance of Rights and Protocols in Disaster Response
Celebrate World Wellbeing Week This June
Official book launch at Bournemouth University
Take a Break: Join the Creative Wellbeing Event
Psychology, Psychiatry and Neuroscience academics – would you like to get more involved in preparing our next REF submission?
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease